This article provides a comprehensive comparison for researchers and drug development professionals on two primary strategies for inhibiting SH2 domain-mediated protein-protein interactions: small molecules and peptidomimetics.
This review provides a comprehensive comparative analysis of the Src Homology 2 (SH2) domains of STAT1 and STAT3, transcription factors critical in immunity, inflammation, and cancer.
Constitutive activation of the JAK-STAT pathway is a hallmark of numerous cancers and autoimmune diseases, driving the development of targeted inhibitors.
Targeting Src Homology 2 (SH2) domains represents a promising therapeutic strategy for modulating dysregulated cell signaling in cancer and other diseases.
This article provides a comprehensive analysis of rapid off-rates in SH2 domain-phosphopeptide interactions, a critical feature for ensuring dynamic and specific cellular signaling.
Targeting the shallow binding surfaces of Src Homology 2 (SH2) domains represents a significant challenge and opportunity in therapeutic development, particularly for cancer and neurodegenerative diseases.
The Signal Transducer and Activator of Transcription (STAT) proteins are critical transcription factors whose dysregulation drives numerous diseases, particularly cancer.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for understanding, performing, and troubleshooting STAT protein dimerization assays in cellular systems.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing SH2 domain structural models to improve the success rate of virtual screening.
This article provides a comprehensive analysis of the strategies and challenges in achieving high selectivity between the SH2 domains of STAT and Src-family kinases (SFKs), a critical goal for developing...